Notch promotes neural lineage entry by pluripotent embryonic stem cells by Lowell, Sally et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notch promotes neural lineage entry by pluripotent embryonic
stem cells
Citation for published version:
Lowell, S, Benchoua, A, Heavey, B & Smith, AG 2006, 'Notch promotes neural lineage entry by pluripotent
embryonic stem cells' PLoS Biology, vol 4, no. 5, e121., 10.1371/journal.pbio.0040121
Digital Object Identifier (DOI):
10.1371/journal.pbio.0040121
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
PLoS Biology
Publisher Rights Statement:
This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
Notch Promotes Neural Lineage Entry
by Pluripotent Embryonic Stem Cells
Sally Lowell
1*
, Alexandra Benchoua
1,2
, Barry Heavey
1
, Austin G. Smith
1,3*
1 Centre Development in Stem Cell Biology, Institute for Stem Cell Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2 INSERM U
421/I-STEM, Faculte´ de Me´decine, Evry-Cedex, France, 3 Institute for Stem Cell Biology, University of Cambridge, Cambridge, United Kingdom
A central challenge in embryonic stem (ES) cell biology is to understand how to impose direction on primary lineage
commitment. In basal culture conditions, the majority of ES cells convert asynchronously into neural cells. However,
many cells resist differentiation and others adopt nonneural fates. Mosaic activation of the neural reporter Sox-green
fluorescent protein suggests regulation by cell-cell interactions. We detected expression of Notch receptors and
ligands in mouse ES cells and investigated the role of this pathway. Genetic manipulation to activate Notch
constitutively does not alter the stem cell phenotype. However, upon withdrawal of self-renewal stimuli,
differentiation is directed rapidly and exclusively into the neural lineage. Conversely, pharmacological or genetic
interference with Notch signalling suppresses the neural fate choice. Notch promotion of neural commitment requires
parallel signalling through the fibroblast growth factor receptor. Stromal cells expressing Notch ligand stimulate
neural specification of human ES cells, indicating that this is a conserved pathway in pluripotent stem cells. These
findings define an unexpected and decisive role for Notch in ES cell fate determination. Limiting activation of
endogenous Notch results in heterogeneous lineage commitment. Manipulation of Notch signalling is therefore likely
to be a key factor in taking command of ES cell lineage choice.
Citation: Lowell S, Benchoua A, Heavey B, Smith AG (2006) Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol 4(5): e121. DOI: 10.1371/
journal.pbio.0040121
Introduction
Embryonic stem (ES) cells can generate all somatic cell
types. They constitute a unique cellular system for uncovering
the molecular basis of pluripotency and delineating mecha-
nisms of primary lineage commitment. ES cells also present
opportunities for disease modelling, pharmacological screen-
ing, and cell based therapies. A key challenge is to understand
the cues that direct ES cells into particular developmental
pathways. Conventional embryoid body differentiation pro-
tocols generate a chaotic mixture of differentiated cell types
[1]. Selective regimes can be used to enrich for cell types of
interest [2,3], but the initial lineage commitment process
remains obscure and uncontrolled.
Conditions have been established for monolayer differ-
entiation of ES cells [4–6], reducing the complexity
compared with multicellular aggregation or coculture
systems. On withdrawal of self-renewal stimuli, ES cells will
readily generate neural progenitors in adherent monocul-
ture. Neural commitment requires the absence of exoge-
nous serum factors or bone morphogenetic proteins
(BMPs), which act as potent antineural factors, and appears
to be driven by autocrine signals, including ﬁbroblast
growth factors [7]. However, even under these simple
culture conditions in which all cells are in a similar
environment, 30% to 40% of cells resist neural speciﬁca-
tion. Of these, around half differentiate into nonneural
lineages, while the others remain as ES cells. The failure of
the latter cells to differentiate into the neural lineage is not
due to an intrinsic lack of neural potential: they are often
able to differentiate subsequently, either within the same
culture or after replating. This implies either that a neural
inductive signal is in limiting supply, or that antineural
signals are prevalent. Furthermore, newly born neural cells,
visualised using the vital reporter of neural speciﬁcation
Sox1GFP [8], are closely interspersed with undifferentiated
cells in a salt-and-pepper pattern (see below), indicating
intraclonal rather than interclonal variation. These obser-
vations suggest that local cell-cell interactions regulate
neural speciﬁcation.
Notch signalling is used in many different tissues to
regulate differentiation decisions by mediating signalling
between adjacent cells [9]. This pathway is classically deployed
to restrict the spread of cell differentiation, a process called
lateral inhibition [10]. In other contexts, however, Notch
promotes neighbouring cells to adopt the same fate, lateral
induction [11]. In this study we report that Notch receptors
and ligands are expressed in ES cells where they play a
previously unsuspected role in the promotion of primary
neural fate.
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Results
Undifferentiated ES Cells Express Notch Receptors and
Ligands
To assess a potential contribution of the Notch pathway to
ES cell fate decisions, we surveyed expression of Notch
receptors and ligands in undifferentiated mouse ES cells. To
this end, we made use of Oct4-GiP ES cells in which a
puromycin resistance gene is expressed under the control of
the pluripotent cell-speciﬁc Oct4 promoter, such that
selection in puromycin eliminates differentiated cells
[12,13]. Notch1 and its ligands, Jagged1, Jagged2, and Delta3,
are readily detected by RT-PCR on total RNA prepared from
puriﬁed Oct4-GiP ES cells (Figure 1A). By ﬂuorescence
activated cell sorter (FACS) analysis using a single-chain Fv
antibody, we found that around half of undifferentiated ES
cells express Jagged1 (Figure 1B).
Constitutive Expression of NotchIC in Sox1 Reporter
ES Cells
Notch signal transduction is mediated via proteolytic
cleavages at the cell membrane upon ligand binding. The
end effect is to release the Notch intracellular domain
(NotchIC), which translocates to the nucleus and binds to
the RBPJk protein (also known as CSL), converting it from a
transcriptional repressor to an activator [9]. The requirement
for ligand can by bypassed by expression of recombinant
NotchIC [14]. We introduced NotchIC into ES cells via
episomal transduction using the high-expression pPyCAGIP
vector [15]. Transfected cells exhibited a massive increase in
Notch activity (1,600 6 500-fold increase according to a
12xRBPJk-luciferase reporter assay). They stopped dividing,
ﬂattened and spread over the culture surface, and did not
survive beyond a few days (unpublished data). This suggests
that very high expression of NotchIC is toxic, although it is
also possible that it induces differentiation into a cell type
that cannot survive under these culture conditions. We
therefore devised a strategy for achieving moderate expres-
sion of NotchIC, based on targeting into the ROSA26 locus
[16], which drives ubiquitous but relatively moderate ex-
pression. We preceded the NotchIC sequence with a ﬂoxed
transcriptional termination sequence and PGKneo cassette,
such that expression was dependent upon Cre recombinase
(CRE) activation. IRES-human CD2 was appended 39 to the
NotchIC. Human CD2 is a cell surface molecule with no
apparent phenotypic effect on mouse cells, used here as a tag
to indicate NotchIC expression. Targeting was carried out in
46C ES cells that harbour a knock-in of GFP to one allele of
the neural speciﬁcation marker gene Sox1 [8] and thus act as a
convenient experimental system for monitoring neural
induction [7,17]. A clonal line of NotchIC-targeted ES cells
was transfected with CRE to excise the termination sequence
and PGKneo, thereby activating constitutive transcription of
NotchIC-IRES-CD2 under control of ROSA26 regulatory
elements. The successfully deleted population, designated
‘‘R26NotchIC cells,’’ was separated from the undeleted
Figure 1. R26NotchIC Does Not Impair ES Cell Self-Renewal
(A) RT-PCR for Notch receptors and ligands in Oct4-GiP ES cells selected in puromycin (‘‘purified ES cells’’). E13.5 neural tissue was used as a positive
control.
(B) FACS analysis of Jagged1 expression in live unpermeabilised 46C ES cells using single-chain antibody to Jagged1. NS cells [42] were used as a
positive control and a single-chain antibody to the irrelevant intracellular antigen Desmin was used for the negative control.
(C) FACS analysis of CD2 expression in R26NotchIC cells with parental 46C ES cells as controls.
(D–F) Analysis of R26NotchIC ES cells or parental control 46C ES cells after 10 to 12 passages in LIFþ serum. (D) R26NotchIC ES cells under phase contrast
or stained for ES cell markers as indicated (average of three independent samples). (E) Quantitative RT-PCR analysis of ES cell markers, normalised to
GAPDH, and displayed relative to expression in 46C ES cells. (F) FACS analysis of Sox1GFP expression.
DOI: 10.1371/journal.pbio.0040121.g001
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population by FACS based on CD2 expression (Figure 1C).
The undeleted population and parental 46C cells were used
as independent control populations and behaved similarly in
all experiments. A second independently targeted and
excised clone yielded similar results to those described below.
To conﬁrm that NotchIC is expressed and functional in the
R26NotchIC cells, we used the 12xRBPJk-luciferase assay. The
relative increase in Notch activity in R26NotchIC cells
compared with control populations was on average 6 6 2-
fold when cells were maintained in the presence of leukemia
inhibitory factor (LIF) and serum.
Under self-renewal culture conditions in the presence of
LIF and serum or BMP4 [18,19], R26NotchIC ES cells show no
overt difference in growth rate or undifferentiated morphol-
ogy compared to either undeleted or parental 46C ES cells.
Population doubling times were similar over more than 20
passages (unpublished data), and R26NotchIC cells express
pluripotency markers such as Oct4 and Nanog [20], and lack
markers of differentiation (Figure 1D–1F and unpublished
data). They have a modal average of 40 chromosomes in
metaphase spreads. We conclude that moderate levels of
activated Notch do not impair ES cell self-renewal.
R26NotchIC Cells Undergo Accelerated and High-
Frequency Neural Specification
We then examined the response of R26NotchIC ES cells to
withdrawal of self-renewal stimuli. We transferred NotchIC
or control ES cells into a differentiation induction regime
comprising adherent monolayer culture in the absence of
exogenous growth factors (described in detail in [21]). These
conditions are permissive for neural commitment driven by
autocrine signalling [7]. Interestingly, we found that Notch
activity, measured by the RBPJk-luciferase reporter, in-
creased almost 4-fold under these conditions. Cells were
harvested and analysed by ﬂow cytometry for Sox1GFP
expression every 12 h. As previously described [7], control
ES cells generate GFPþ cells progressively after an initial lag:
fewer than 2% could be detected after 24 h and only 116 1%
after 48 h. In contrast, NotchIC cultures (Figure 2) contained
9 6 1% Sox1GFPþ cells at 24 h, increasing to 32 6 3% by the
second day (Figure 2A and 2B). In an alternative neural
differentiation protocol, coculture on stromal PA6 cells [22],
R26NotchIC cells also showed accelerated acquisition of
Sox1GFP expression compared with control cells (unpub-
lished data).
The distribution of Sox1GFPþ cells during monolayer
differentiation was monitored by ﬂuorescence microscopy.
In control ES cell cultures, GFP-positive cells initially appear
randomly interspersed with GFP-negative cells in a ‘‘salt and
pepper’’ pattern (Figure 2C and 2E). In contrast, in NotchIC
cultures, GFPþ cells appear as coherent groups (Figure 2D
and 2F). To corroborate that Sox1GFP marked entry into the
neural lineage, we immunostained cultures for the early
neural marker, nestin, and found that this was expressed in a
similar pattern to sox1, although it tended to appear
approximately 12 to 24 h later than the ﬁrst GFPþ cells
(Figure 2G and 2H). We also noted a difference in the
variability of GFP intensity between cells: control cultures
contain a mixture of bright and less intensely GFP positive
cells (Figure 2I [Control cells] and [8]), whereas NotchIC cells
show uniformly moderate GFP expression (Figure 2I [Not-
chIC cells]).
A direct effect of Notch at the onset of ES cell differ-
entiation is indicated by the kinetics and pattern of gene
regulation. We examined two key marker genes. Oct4 is a
critical determinant of the pluripotent state [23] that is
downregulated early during somatic differentiation. Fibro-
blast growth factor (FGF)5 is the earliest characterised marker
of ES cell progression to differentiation [24]. Oct4 is expressed
at similar levels in self-renewing R26NotchIC ES cells as in
control ES cells (Figures 1E and 2J). However, within 24 h of
LIF and serum withdrawal, Oct4 mRNA drops by almost two
thirds in R26NotchIC cells (p , 0.05, Figure 2J), while there is
only a slight decrease in control cells (Figure 2J). FGF-5 is ﬁrst
expressed in post-implantation epiblast in vivo [25]. In vitro,
FGF5 mRNA is upregulated transiently at initial stages of
lineage commitment of ES cells and then downregulated in
deﬁnitive germ layer precursors [25,26]. The low level of FGF5
transcript in self-renewing R26NotchIC cells (Figure 2K [ES])
indicates that they remain in the naı¨ve ES cell state and have
not advanced to amoremature egg cylinder stage [24]. Control
ES cells acquire FGF5mRNA progressively over several days of
monolayer differentiation. In contrast, NotchIC-overexpress-
ing ES cells show a sharp increase in FGF5 mRNA just 24 h
after withdrawal of self-renewal factors, consistent with an
early and synchronised entry into differentiation (Figure 2K).
Notch signalling could also act after speciﬁcation to
increase the survival and/or proliferation of neural precur-
sors. We consider that this would be unlikely to contribute
signiﬁcantly to the observed initial increase in frequency of
Sox1GFP expressing cells, however, because their numbers
rise after only 24 h, before the detection of neural
speciﬁcation in control ES cell populations (Figure 2B).
Moreover, the frequency of apoptotic cell death detected by
terminal deoxyribonucleotidyl transferase-mediated dUTP-
digoxigenin nick end labelling (TUNEL) staining is un-
changed at this time and the growth rate of NotchIC and
control populations is indistinguishable during the course of
the experiment (Figure S1).
To test further whether Notch directly promotes ES cell
differentiation, we examined the density dependence of
neural speciﬁcation in R26NotchIC cultures. Neural induc-
tion of ES cells during monolayer differentiation is strongly
inhibited by even modest increases in cell density [21]. By
contrast, R26NotchIC cells generate large numbers of
Sox1GFPþ neural precursors at densities that almost com-
pletely eliminate neural speciﬁcation in control cultures
(Figure 2L and 2M).
Collectively, these data indicate that NotchIC acts at the
initial stages of ES cell differentiation to promote the
transition into mature epiblast and subsequently neuro-
ectoderm.
The Effect of NotchIC Is Not Restricted to 46C ES Cells
ES cells are mutable in culture, and it is therefore
important to validate any observed phenotypic effect on
more than one cell line. To test whether the effects of
NotchIC are generalisable, we took advantage of an inde-
pendent E14Tg2a derivative, RC, containing the coding
sequence for the Cre-ERT2 fusion [27] targeted into the
ROSA26 locus (L. Grotewold and AGS, unpublished data). We
targeted our NotchIC expression construct into the second
ROSA26 locus of RC cells and induced deletion of the
transcriptional stop sequence by treatment for 4 d with 1 lM
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4-hydroxy-tamoxifen. We then used FACS to collect the
NotchIC-CD2þ population and tested these cells in our
monolayer differentiation protocol. As with the 46C-derived
cell line, RC-derived NotchIC cells began to generate
signiﬁcant numbers of nestin-positive cells with a neuro-
epithelial morphology during the second day of monolayer
differentiation, while almost all control cells remained nestin-
negative with an undifferentiated ES cell morphology at this
time (unpublished data).
Requirement for Notch Signalling for Efficient Neural
Specification of ES Cells
We next asked whether endogenous Notch signalling
regulates neural speciﬁcation of ES cells during monolayer
Figure 2. R26NotchIC Cells Undergo Accelerated Neural Specification
R26NotchIC ES cells or parental control 46C cells cultured under monolayer differentiation conditions.
(A) Typical FACS profile of Sox1GFP expression after 48 h. Sox1GFPþ cells were scored using gate M1.
(B) Proportion of Sox1GFPþ cells at various time points (average of triplicates).
(C–H) Intact cultures at 72 h of monolayer differentiation, shown in phase contrast or stained for markers as indicated.
(I) Typical FACS profile of Sox1GFP expression after 5 d. M1 is the gate used throughout to quantify the proportion Sox1GFPþ cells: note that this FACS
profile indicates a more striking difference between control and NotchIC populations than is reflected by our conservative quantification.
(J and K) Quantitative RT-PCR for Oct4 and for FGF5 during monolayer differentiation of R26NotchIC cells (NotchIC) or control parental 46C cells. Levels
were normalised to GAPDH and are displayed relative to expression in 46C ES cells.
(L and M) FACS analysis of the proportion of Sox1GFPþ cells for R26-NotchIC cells or parental 46C cells at various time points from triplicate cultures at
normal density (104 cells/cm2) or higher density (33 104 cells/cm2) (average of triplicates).
DOI: 10.1371/journal.pbio.0040121.g002
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differentiation. We used both pharmacological and genetic
approaches to interfere with Notch activity.
A critical step in activating Notch is cleavage by c-secretase
to release the intracellular domain. The c-secretase inhibitor
L-685,458 is an effective inhibitor of Notch activation [28].
When 46C ES cells are exposed to this c-secretase inhibitor
during the monolayer differentiation protocol, the majority
of cells fail to become Sox1GFPþ neural cells. Over 6 d of
differentiation (Figure 3), fewer than 10% of inhibitor-
treated cells become Sox1GFPþ compared with around 50%
of cells exposed to DMSO vehicle (Figure 3A–3D, p , 0.001).
Most inhibitor-treated cells remain Oct4 positive during this
period (Figure 3A). Their uncommitted status is conﬁrmed on
withdrawal of the inhibitor on day 5, which results in
emergence of Sox1GFP in the majority of cells over the
following 5 d (unpublished data). However, if the inhibitor
was maintained beyond 5 d, cells progressively began to
differentiate into a nonneural ﬂattened morphology, lacking
the neural markers Sox1GFP, brain lipid binding protein
(BLBP), and nestin such that by the tenth day very few
undifferentiated ES cells remain (unpublished data). Our
observations suggest that blockade of c-secretase initially
delays lineage commitment and then diverts ES cells into a
nonneural fate.
c-Secretase inhibitors are not speciﬁc to Notch, however.
These compounds also inhibit membrane cleavage of other
molecules, including N-cadherin, ErbB4, and CD44 [29].
Therefore, we examined the effect of the inhibitor on
R26NotchIC cells. As these cells contain a pre-cleaved
NotchIC fragment, they are immune to blockade of Notch
cleavage whilst remaining vulnerable to any side effects of the
inhibitor. Acquisition of Sox1GFP expression by R26NotchIC
cells was unaffected by L-685,458 (Figure 3E and 3F). This
establishes that the anti-neural effects of the inhibitor are
speciﬁcally due to a block in Notch signalling.
Similar experiments were carried out using two alternative
neural differentiation protocols: coculture with PA6 stromal
cells [22] and formation of EBs in the presence of retinoic
acid (RA) [30]. In both cases, the c-secretase inhibitor
signiﬁcantly reduced the proportion of cells that became
Sox1GFPþ (Figure S2, p , 0.05, and unpublished data).
As an alternative loss-of-function approach, we used ES
cells that lack the critical downstream mediator of Notch
signalling, RBPJk [31]. These cells have previously been
reported to have some limited capacity for neural differ-
entiation [32]. We examined three independent clones of
RBPJk-null ES cells (No. 24, 49, and 68) plus their parental
wild-type line (D3). Since these cells do not contain a Sox1GFP
reporter and Sox1 cannot be unambiguously detected by
immunohistochemistry, we instead used differential Sox2 and
Oct4 immunostaining to identify neural cells. Sox2 is a pan-
neuroepithelial marker like Sox1 [33], but it also marks
undifferentiated ES cells. We carried out double staining for
Sox2 and Oct4 and scored cells that were Sox2þ and Oct4 as
committed neural precursors. During expansion in LIF plus
serum, RBPJk-null cells resembled their parental ES cells and
uniformly expressed both Oct4 and Sox2. After transferring
into N2B27 medium to initiate monolayer neural differ-
entiation, parental cells began to generate Sox2þ, Oct4 cells
from the third day, peaking at around 60% by day 5 (Figure
Figure 3. Notch Signalling Is Required for Efficient Neural Specification of ES Cells
(A–F) Monolayer differentiation of 46C cells (A–D) or R26NotchIC cells (E and F) exposed to 4 lM c-secretase inhibitor or to equivalent amounts of
DMSO diluent. (A and B) Sox1GFP and immunostaining for Oct4 on day 5. (C and E) Typical FACS profiles for Sox1GFP on day 6. (D and F) Proportions of
Sox1GFPþ cells (average of triplicates).
(G–P) Monolayer differentiation of RBPJk-null ES cells and the parental D3 ES cell line. Cultures were fixed and stained as indicated on day 2 (G and H) or
day 6 (I–P).
(Q) Proportion of Sox2þ Oct4 cells on day 6 (average of duplicates).
DOI: 10.1371/journal.pbio.0040121.g003
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3J, 3L, and 3Q), comparable to differentiation of 46C ES cells
(Figure 2). In contrast, three independent lines of RBPJk-null
cells generated far fewer (less than 10%) Sox2þ, Oct4 cells
(Figure 3I, 3K, and 3Q, p , 0.05). Cell death was minimal in
both RBPJk-null and control populations. Similar to the cells
treated with the pharmacological Notch inhibitor, the RBPJk-
null ES cells either retained Oct4, indicating failure to
differentiate, or lost expression of both markers and became
larger and ﬂatter, indicating nonneural differentiation. The
proportions of nestinþ cells, Pax6þ cells, and BLBPþ cells
were also much lower in the RBPJk-null cells compared with
control cultures (Figures 3M, 3N, and S3). Furthermore, we
noted that many of the RBPJk nestinþ cells had a large ﬂat
morphology and were negative for Sox2, indicating that they
are not neural progenitors. This is consistent with previous
evidence that nestin is not an exclusive neural marker [34,35]
and should be used with caution in attributing neural
identity. Finally, in contrast to the plentiful TuJ1þ cells
generated by parental cells after 5 d of monolayer differ-
entiation, RBPJk-null cells generated only a few small foci of
TuJ1þ cells in keeping with the dramatic reduction in the
number of neural progenitors (Figures 3O, 3P, and S3).
Therefore, both pharmacological inhibition and genetic
disruption of Notch signalling severely reduce commitment
of ES cells to the neural lineage, although neither completely
blocks neural fate (see Discussion).
Notch Acts in Combination with FGF Signalling to
Promote Neural Specification
In vertebrate embryos, neural induction requires FGF
signalling through the Ras-Erk pathway [36–38]. This also
appears to be true for ES cells, where the initial stimulus is
most likely provided by autocrine FGF4 [21]. We tested
whether NotchIC could bypass this requirement using two
pharmacological inhibitors (Figure 4). SU5402 inhibits the
FGF receptor tyrosine kinase [39], and PD184352 blocks
Mek1/2, upstream of Erk1 and Erk2 [40]. These inhibitors are
both able to block neural speciﬁcation of ES cells [7,8]
(unpublished data). R26NotchIC cells remain susceptible to
blockade of neural induction by these inhibitors. In the
presence of these agents they continue to proliferate in an
apparently undifferentiated Oct4þ state for at least 5 d with
minimal generation of Sox1GFPþ derivatives (Figure 4B).
These ﬁndings indicate that FGF and Notch act combinato-
rially in the neural induction cascade. It remains to be
determined whether Notch is activated independently of or
consequent to FGF signalling.
NotchIC Cannot Overcome the Serum Inhibition of Neural
Differentiation
Serum is a potent antagonist of neural differentiation, but
addition of 5 lM RA to differentiating embryoid bodies (EBs)
overcomes this inhibitory effect by unknown mechanisms
[30]. Interestingly, although inhibition by the c-secretase
inhibitor suggests that Notch is important for RA-induced
neural differentiation, we found that NotchIC is not sufﬁcient
to substitute for RA for neural differentiation of EBs in
serum (Figure S4A). We noticed, however, that RA-treated
R26NotchIC EBs contained uniformly distributed Sox1GFPþ
cells, in contrast with control EBs, which contained patches of
Sox1GFPþ cells and were surrounded by a Sox1GFP outer
layer (Figure S4). Thus, NotchIC appears to have a similar
effect in homogenising the distribution of Sox1GFPþ cells
generated during two different types of differentiation
protocols: EB culture in the presence of RA and serum, and
serum-free monolayer culture (compare Figure S4A with
Figure 2I). This may indicate that part of the mechanism by
which RA acts could be to liberate the Notch pathway from
the suppressive effects of serum.
R26NotchIC Neural Precursors Transit from Sox1þ to Sox1
Status
During parental 46C-cell lineage commitment (Figure 5),
Sox1GFPþ cells do not reach a maximum until the ﬁfth day
and then remain at this plateau for several days (Figure 5A).
In contrast, the proportion of Sox1GFPþ cells in R26NotchIC
cultures peaks by day 3 and begins to decline soon afterwards
(Figure 5A). On day 3, R26NotchIC cells ﬁrst begin to express
BLBP, a marker of more mature neural precursors that
appears much later in parental cell differentiation (Figure
5B). This is followed between day 4 and day 6 by transition to
bipolar morphology in many of the cells (Figure 5C). These
bipolar cells are immunopositive for BLBP (Figure 5C and
5D) and RC2 (not shown) and negative for GFAP, character-
istics of neural precursor cells in vivo and of neural stem (NS)
cells in vitro [41,42]. By the ﬁfth day, at least 50% of NotchIC
cells express BLBP, compared with fewer than 5% of control
cells. Quantitative RT-PCR conﬁrmed that BLBP was induced
in R26NotchIC cells much earlier than in control cells (Figure
5H). Control ES cells similarly only develop bipolar morphol-
ogy at later time points (Figure 5F and 5G). Sox1GFP
expression is downregulated as BLBP is upregulated, such
that the two markers are generally mutually exclusive.
However, we do observe some BLBPþ cells at early time
points in R26NotchIC differentiation that coexpress weak
levels of GFP, likely due to perdurance of GFP protein (Figure
5I). These observations suggest that R26NotchIC-derived
early neural cells rapidly progress through the Sox1þ pan-
neuroepithelial stage and convert to Sox1 BLBPþ neural
cells. This explains why numbers of Sox1GFPþ cells do not
continue to increase beyond the third day in monolayer
differentiation.
NotchIC Suppresses Nonneural Differentiation
In Figure 6A–6D, we used a combination of BLBP
immunostaining and Sox1GFP, both visualised together in
Figure 4. NotchIC Does Not Bypass the Requirement for FGF Signalling
in Neural Specification
(A) R26NotchIC cells or parental control 46C cells were cultured in
triplicate for 3 d in the presence of 4 lM PD184352, 5 lM SU5402, or in
an equivalent concentration of DMSO diluent (‘‘No inhibitor’’) and the
proportion of Sox1GFPþ cells analysed by FACS on day 3.
(B) Intact cultures were immunostained for Oct4 on day 5 to visualise
undifferentiated ES cells.
DOI: 10.1371/journal.pbio.0040121.g004
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green in order to show all neural progenitors, with Oct4
immunostaining in red to indicate undifferentiated ES cells.
In NotchIC cultures, the vast majority of the cells express
neural markers by day 3 (Figure 6A). Only a minor
subpopulation resists neural differentiation (less than 10%)
and persists as undifferentiated ES cells. Practically all cells
can be accounted for by expression of either neural or ES
markers at either day 3 or day 6 (Figure 6A and 6B). This
contrasts with control cultures, where there are more
persisting ES cells, but in addition, 15% to 30% of cells lack
neural or ES cell markers and exhibit nonneural differ-
entiated morphologies by day 6 (Figure 6D). Many of these
cells express cytokeratin 8, a differentiation marker that is
not present in ES cells or neural lineages (Figure 6F). We
carried out quantitative RT-PCR to measure the expression
of endoderm and mesoderm markers on the sixth day of
monolayer differentiation (Figure 6E). Several nonneural
markers were readily detected in parental cell samples, in
marked contrast to the barely detectable expression levels in
R26NotchIC cell. These observations indicate that not only
does Notch promote neural lineage entry but it also
simultaneously suppresses nonneural commitment.
R26-NotchIC ES also showed a marked reduction in
mesoderm differentiation when tested under an inductive
differentiation protocol based on monolayer culture on
collagen IV in thepresenceof batch-tested serum [4] (Figure S5).
NotchIC Allows for the Maintenance of BLBPþCells Rather
than Promoting Their Rapid Terminal Differentiation into
Astrocytes or Neurons
The Notch signalling pathway has been reported to either
promote expansion of neural progenitor cells [43], or to
promote their differentiation into astrocytes [44], depending
on the developmental stage and context. We observed that
the majority of NotchIC cells persist as BLBPþ nestinþ RC2þ
cells for at least 3 wk in the absence of added growth factors
Figure 5. R26NotchIC Cells Lose Sox1 and Acquire BLBP Expression
R26NotchIC ES cells or parental control 46C cells cultured under monolayer differentiation conditions.
(A) Proportion of Sox1GFPþ cells at various time points measured by FACS analysis.
(B–G) Cultures at various time points shown in phase contrast or stained for markers as indicated.
(H) Quantitative RT-PCR for BLBP normalised to GAPDH and displayed relative to expression in day 7 46C ES cells.
(I) R26NotchIC cells at day 7 of monolayer differentiation stained with an antibody to GFP in order to amplify detection of Sox1GFP (green) together
with an antibody to BLBP (red).
(J) Schematic diagram to illustrate the transition of ES cells into Sox1GFPþ neuroepithelial progenitors and then into BLBPþ bipolar neural progenitors.
DOI: 10.1371/journal.pbio.0040121.g005
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(Figure S6E, S6G, and unpublished data). During the second
week of culture, neuron-like cells that stained with TuJ1
appeared (Figure S6A) but in fewer numbers than in control
cultures and signiﬁcantly outnumbered by undifferentiated
BLBPþ cells (Figure S6B, S6H, and S6I). GFAP immunoposi-
tivity, indicative of astrocyte differentiation, was rarely
observed until the third week and even then only in a low
number of cells (Figure S6K). However, upon transfer to
serum-containing medium, the R26NotchIC BLBPþ cells
efﬁciently differentiate into GFAPþ astrocytes (Figure S6C).
We conclude that R26NotchIC restrains but does not
irreversibly block terminal differentiation.
Notch Promotes Neural Specification in Human ES Cells
Notch pathway genes have been reported to be expressed
in human ES cells [45,46]. We therefore investigated whether
the role of Notch in neural differentiation is conserved in
human ES (hES) cells. We ﬁrst conﬁrmed that the Notch
ligands Jagged1, Jagged2, Delta1, and Delta3 could all be
readily detected in human ES cells by RT-PCR (Figure S7).
Mis-expression of Notch ligands in feeder cells has been
shown to activate Notch in other cell types [47,48], so we
decided to employ this strategy with hES cells.
We made use of OP9 cells that stably express the Notch
ligand Delta1 together with GFP, through retroviral trans-
duction (OP9-Delta1) [49]. Control OP9 feeder cells had been
transduced with a GFP-only retrovirus (OP9-EV). When hES
cells were plated onto OP9-EV feeder layers in serum-free
medium containing bFGF but no LIF or BMP4, the majority
of cells maintained an ES-like morphology after 1 wk. In
contrast, when cells were plated onto OP9-Dl1 feeders in the
same medium, the edges of the colonies, where they contact
the GFPþ OP9-Dl1 feeder cells, underwent a morphological
change within the ﬁrst week (Figure 7). They became compact
and elongated with barely distinguishable nuclei (Figure 7A,
region between dotted lines). Antibody staining conﬁrmed
that these cells were negative for the ES markers TRA1/60 and
TRA 1/81 (unpublished data) and positive for Sox1, Nestin,
and Pax6 (Figure 7B, 7C, and unpublished data). In human ES
cells, Pax6 is the earliest known marker of neural differ-
entiation, appearing several days before Sox1 begins to be
expressed [50,51]. We carried out quantiﬁcation of this
marker using image analysis software. This conﬁrmed a
signiﬁcant increase in both the number of Pax6þ colonies
(colonies containing more than ten Pax6þ cells) and in the
area that is Pax6þ within each of these colonies in OP9-Dl1–
supported cultures in comparison with OP9-EV colonies
(Figure 7D–7G, 7J, and 7K, p , 0.01). The positive effect of
OP9-Dl1 feeders on neural differentiation appeared to be
speciﬁcally due to activation of Notch signalling, because it
could be blocked by adding the gamma secretase inhibitor
(Figure 7H–7K, p , 0.01). Exposure to neither Delta1 nor the
c-secretase inhibitor had any discernible effect on cell
number or viability.
We went on to test whether endogenous Notch signalling is
required for neural differentiation in hES cells. For these
Figure 6. NotchIC Inhibits Nonneural Differentiation
(A–D) R26NotchIC cells (NotchIC) or parental 46C cells (control) cultured under monolayer differentiation conditions and stained for Oct4 (red) to
indicate ES cells together with a combination of BLBP and GFP (green) to indicate both types of neural progenitor together.
(E) qRT-PCR for various markers in R26NotchIC cells relative to parental 46C cells after 6 d of monolayer differentiation. Data are averaged from at least
three independent experiments and normalised to GAPDH. Notch1 primers amplify within the NotchIC and detect both endogenous and exogenous
transcripts.
(F) R26NotchIC cells (NotchIC) or parental 46C cells (control) cultured under monolayer differentiation conditions and stained for cytokeratin 8, a marker
of nonneural differentiation (red) and counterstained with DAPI (blue)
DOI: 10.1371/journal.pbio.0040121.g006
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experiments, we made use of a monolayer neural differ-
entiation protocol adapted from that for mouse ES cells.
Brieﬂy, we removed the hES from feeders and from
exogenous LIF and BMP4 and plated them onto Matrigel in
FGF–only serum-free medium. Under these conditions,
typically around 60% of the culture area loses expression of
the ES cell marker TRA1/81, adopts a neural morphology, and
becomes Sox1þ Pax6þ after 1 wk (Figure 7L, 7M, 7P, 7R, and
7T). In contrast, in the presence of the c-secretase inhibitor,
there is a signiﬁcant reduction in emergence of Pax6þ regions
within the culture (Figure 7M, 7O, 7Q, 7S, and 7T, p , 0.5),
with a corresponding increased persistence of undifferenti-
ated TRA1/81þ ES cells (Figure 7O). The c-secretase inhibitor
had no obvious effect on cell viability or cell number, and the
majority of treated cells retained a healthy hES-like mor-
phology (Figure 7M).
These data suggest that Notch plays a similar role to
promote neural differentiation in human ES cells as it does in
mouse ES cells.
Discussion
Pluripotent ES cells should be a valuable source of neural
cell types for cell biological investigation, neurodegenerative
disease modelling, pharmaceutical screening, and possibly
even regenerative therapies. If ES cells are to be harnessed
effectively for these goals, it will be necessary to develop
robust methods for directing neural commitment and
suppressing differentiation into other lineages. In this study
we have presented evidence for an unsuspected role of the
Notch signalling pathway in promoting and directing primary
fate choice in ES cell differentiation. Activation of Notch thus
emerges as a key tool for steering ES cells toward the neural
fate and away from nonneural fates. Although we have relied
primarily on genetic manipulations to activate Notch, it
Figure 7. Notch Promotes Neural Differentiation of Human ES Cells
(A–I) Human ES cells plated on OP9 feeder cells expressing either GFP only (OP9 EV) or the Notch ligand Delta1 (OP9 Dl1) with c-secretase inhibitor
where indicated (‘‘þinhibitor’’) were cultured for 7 d and stained for markers as indicated. (A) Higher magnification picture to indicate the cell
morphology: the OP9-Dl1 feeders are green and the dotted line demarcates hES cells adjacent to the feeders that have adopted a neural morphology,
while cells more distant from the feeders retain an ES-like morphology.
(J and K) Quantification of Pax6 immunostaining (averages and standard deviations shown from four experiments).
(L–T) Human ES cells grown under monolayer differentiation conditions in the presence of c-secretase inhibitor (‘‘inhibitor’’) or DMSO vehicle and
stained for Pax6, Sox1, or TRA1/81 as indicated. T shows quantification of Pax6 immunostaining (averages and standard deviations from four
experiments).
DOI: 10.1371/journal.pbio.0040121.g007
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should in principle be possible to achieve the same result by
adding specially engineered soluble forms of Notch ligands or
other forms of Notch agonist to the culture medium [52].
In the presence of LIF, moderate expression of an activated
form of Notch does not interfere with the self-renewal of ES
cells. However, after removal of self-renewal signals, NotchIC
signiﬁcantly increases the rate and frequency of neural
speciﬁcation in serum-free media whilst blocking differ-
entiation into nonneural lineages. Conversely, pharmacolog-
ical inhibition of Notch signalling or genetic ablation of
RBPJk signiﬁcantly reduce the proportion of ES cells that
enter the neural lineage, temporarily arresting differentia-
tion and then diverting ES cells into nonneural fates. These
data suggest that endogenous Notch signalling both mediates
and is a limiting factor for neural speciﬁcation in ES cell
cultures. In addition, we ﬁnd that moderate levels of activated
Notch from the R26 locus promotes the generation and
expansion of BLBPþ neural cells and suppresses terminal
neuronal differentiation without promoting astrocyte differ-
entiation. Thus, the Notch pathway directs lineage commit-
ment in ES cells but restrains differentiation in neural stem/
progenitor cells.
Previously we have reported that autocrine FGF signalling
promotes neural conversion of ES cells in the absence of
serum, BMP, or Wnts [7,17,53]. The FGF signal does not
appear to be limiting for this lineage choice since added FGF
has little effect except at low cell densities [21]. R26NotchIC
in contrast enhances neural speciﬁcation over a range of cell
densities. However, it is not dominant over all other signals.
Notch is not sufﬁcient to drive neural speciﬁcation in the
presence of serum and in the serum-free monolayer protocol
the effect of R26NotchIC is diminished at very high cell
densities. Furthermore, even at standard cell densities, 5% to
10% of cells still resist differentiation. This is approximately
half the number observed for control cultures but nonethe-
less raises the question why do some ES cells elude neural
commitment? These cells are not differentiation defective as
they generally undergo neural speciﬁcation if replated into a
fresh monolayer differentiation. Possibly Notch responsive-
ness oscillates in ES cell cultures as reported for embryonic
tissues [54] or occasional predifferentiated cells in the
cultures secrete sufﬁciently high local levels of LIF and/or
BMP to sustain local self-renewal [55].
Forced expression of Sox1 in ES cells has a similar effect to
NotchIC in promoting more uniform neural speciﬁcation
[56]. The pharmacological Notch inhibitor appears to have
little or no impact on the initial onset of neural speciﬁcation
in the context of Sox1 overexpression (unpublished data).
This suggests that Sox1 is downstream of Notch in the neural
induction cascade and further supports the contention that
Notch acts in the primary phase of neural speciﬁcation in
undifferentiated Sox1 ES cells.
During neural differentiation a proportion of Sox1þ
neuroepithelial cells mature into bipolar Sox1, BLBPþ,
GFAP neural precursor cells with certain features of radial
glia [42]. NotchIC appears to promote this transition, with
BLBPþ cells appearing earlier and in high numbers. In vivo
studies indicate that an activated form of Notch increases the
number of radial glia that emerge from the neuroepithelium
in vivo [57] and from neuroepithelial cells in culture [58] and
that BLBP is a direct target of Notch signalling in radial glial
cells [59]. It is also possible that the precocious generation of
a BLBPþ, GFAP phenotype in the presence of NotchIC is
purely secondary to the accelerated conversion of ES cells
into neuroectoderm. However, the lower peak proportion of
Sox1GFPþ cells suggests that they do not accumulate in this
phase to the same extent as parental cells. Thus, Notch
appears to drive differentiation forward at both the ES cell
and neuroectodermal precursor stage, but then to restrain
terminal differentiation.
BLBPþ cells act as neuronal precursor cells in vivo [59] and
in culture [42]. This raises the question of whether the bulk of
our R26-NotchIC ES-derived cells retain neuronal as well as
astrocyte differentiation potential. We do observe that a
minor subpopulation of these cells spontaneously differ-
entiate into neurons during the course of our experiments
(Figure S6). However, NotchIC is well established as an
inhibitor of overt neuronal differentiation [9], and so it is not
possible to assess the true neuronal differentiation capacity
whilst R26-NotchIC is overexpressed. Future studies using a
cre-revertable or tet-regulatable NotchIC expression system
should make it possible to directly address whether sustained
exposure to active Notch restricts ES-derived neural cells to
an astrocyte fate or maintains neurogenic competence.
Signiﬁcantly, we ﬁnd no acceleration of astrocyte differ-
entiation in response to NotchIC in our experiments. Notch
has been reported to promote astrocyte terminal differ-
entiation, but this appears to be an age-dependent phenom-
enon. For example, NotchIC drives astrocyte differentiation
in adult hippocampal cells [44] but not in earlier neural
progenitors, for example from E11.5 embryonic cortex [60].
Notch has been shown to act in other contexts to promote
neural competence in tissues that would otherwise become
nonneural. Subsequently in the same tissue, Notch can inhibit
ﬁnal differentiation. In the Drosophila eye, Notch has such
sequentially distinct effects, ﬁrst promoting neural compe-
tence and later inhibiting overt neural differentiation [61].
Similarly, in the developing inner ear of the chick activated
Notch promotes generation of sensory patches followed by a
later function to inhibit the differentiation of sensory hair
cells within those sensory patches [11]. Interestingly, Jagged1
appears to be the Notch ligand responsible for mediating this
pro-sensory role of Notch [11]. We ﬁnd that Jagged1 is
expressed in undifferentiated ES cells, consistent with this
being the Notch ligand that drives neural speciﬁcation.
Furthermore, the fact that Jagged1 is expressed only in
around half of cells may explain why Notch activity remains
limiting.
In the developing embryo, neighbouring cells must
continually communicate with each other to coordinate
patterning of tissues. Notch signalling patterns tissues by at
least two types of mechanism. Lateral inhibition mechanisms
ensure that neighbouring cells follow different fates, so that
one single cell type does not dominate within a particular
region [10]. Lateral induction, a form of community effect
[54], acts in the opposite way to ensure that cells within a
particular region adopt the same fate choice. In the context
of neural induction from ES cells, our ﬁndings indicate that
Notch signalling acts to amplify and consolidate neural
speciﬁcation.
The key features of Notch in ES cell fate choice are that it
(1) synchronises the timing of neural speciﬁcation, (2)
homogenises the levels of Sox1 between different cells within
the population, and (3) inhibits nonneural differentiation.
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These observations provoke consideration of a possible role
for Notch signalling in vertebrate germ layer speciﬁcation.
Neural induction in vivo is regulated by an interplay between
FGF, BMP, and Wnt signals [62], but recent data indicate that
a further, as yet unidentiﬁed signalling event is also required
[63]. Our ES cell data raise the possibility that Notch may be a
component of this circuit.
In the mouse embryo, Notch pathways mutants have not
been reported to show defects in gastrulation or primary
neural speciﬁcation [64]. Requirements for Notch signalling
may be masked by redundancy, especially in the case of the
Notch family itself, which has four members. Redundancy is,
however, less likely to be an issue for RBPJk, which is thought
to mediate the downstream response to all four Notches
(although Notch can signal via RBPJk-independent pathways
in some contexts [65]). RBPJk-null embryos develop multiple
abnormalities around E8, dying soon afterward [66]. A nestin-
positive neuroepithelium is present in these embryos but is
reported to be thinner. The mutants are also characterised by
failure of anterior neural tube closure. Therefore, examina-
tion of earlier stages in these embryos could reveal deﬁcien-
cies in generation of neural tissue. Our analysis of the RBPJk
mutant ES cells indicates that they are severely deﬁcient,
although not entirely blocked, in their ability to generate
neural cells. These data are supported by experiments with the
c-secretase inhibitor. Furthermore, Notch1-null or RBPJk-null
ES cells appear biased towards mesodermal differentiation in
both embryoid body and stromal coculture systems (F. Ratke
and T. Schroeder, personal communication).
Nonetheless, RBPJk-dependent Notch signalling appears to
be more signiﬁcant for neural speciﬁcation in ES cells than for
neural induction in vivo. The ES cell data suggest a role of
Notch not as a primary inducer but as an ampliﬁer that
coordinates uniform neural induction within a population,
helping to both synchronise the timing with which cells
respond to inductive cues, notably FGF, and to protect against
nonneural differentiation in face of ﬂuctuations in self-
renewal and differentiation signals. This is reminiscent of the
role of Notch during somitogenesis, coordinating the timing
of cyclic gene expression within each somite [67]. Such a
coordination role may be of greater signiﬁcance for cultured
ES cells, confronted with conﬂicting autocrine, paracrine, and
exogenously provided differentiation cues, than in the
gastrulating embryo where differentiation signals are tightly
restricted, topologically and temporally. Indeed, the challenge
in ES cell biology is precisely to suppress the diversity of
embryonic development and impose unitary lineage commit-
ment. We suggest that manipulation of the Notch pathway
may be a key component in achieving this goal.
Materials and Methods
All experiments were carried out at least three times with similar
results, unless otherwise stated. Error bars represent standard
deviations, and p values are calculated using a two-tailed Student’s
t-test.
Targeting NotchIC into 46C ES cells. Our targeting construct is
based on similar constructs previously used for targeting into the
ROSA locus [16]. It contains a pgk-neo cassette plus a triple-polyA
termination sequence, which together are ﬂanked by loxP sites. This is
followed by the coding sequence for the intracellular domain of
NotchIC [14] followed by an internal ribosomal entry site followed by
the coding sequence for the human cell surface molecule CD2. This
construct was transfected into 46C ES cells [7] or into R26-Cre-ERT2
(RC) cells (L. Grotewald and AGS) by electroporation, and clones
were expanded under G418 selection. Correctly, targeted clones were
identiﬁed by Southern blotting after digestion with EcoRV. The
targeted allele gives an 11-kb band, while the wild-type allele gives a
3.8-kb fragment. Clones of targeted 46C cells were transfected with a
plasmid containing CRE in the CAGS expression unit [68]. Clones of
targeted R26-Cre-ERT2 cells were exposed to 1 lM 4-hydroxy-
tamoxifen for 4 d to induce CRE activity. Cells that failed to undergo
CRE-mediated deletion of the pgk-neo STOP cassette were elimi-
nated by FACS collection of the CD2-positive population.
Luciferase assay. The 12xRBPJk-luciferase Notch reporter con-
struct (gift from U. Lendahl and E. Hansson) was originally described
in [69]. Luciferase assays were carried out using a Dual Luciferase
Reporter Assay System (Promega, Madison, Wisconsin, United States).
Mouse ES cell culture. ES cells were maintained in Glasgow
modiﬁcation of Eagle’s minimal essential medium supplemented with
2-mecaptoethanol, nonessential amino acids, sodium bicarbonate,
10% FCS, and 100 units/ml LIF on gelatinised tissue culture ﬂasks [70].
Mouse ES cell monolayer differentiation. This was described in
detail in [7]. Brieﬂy, ES cells were washed to remove all traces of
serum and then plated onto gelatin-coated tissue culture plastic at a
density of 1 3 104 cells/cm2 in N2B27 serum-free medium. N2B27
consists of a 1:1 ratio of DMEM/F12 and Neurobasal media
supplemented with 0.5% modiﬁed N2 (made in house as described
in [7], 0.5% B27 (GIBCO, San Diego, California, United States), and 2-
mercaptoethanol. Medium was changed every second day. For some
experiments, cells were replated after 7 d onto dishes coated with
laminin and polyornithine. For astrocyte differentiation, the culture
medium was supplemented with 10% FCS after 14 d of serum-free
culture.
Other differentiation protocols. Coculture with PA6 stromal cells
was carried out essentially as described previously [22] except that the
serum-free medium used was N2B27 as described above. Generation
of EBs was carried out as previously described [30]. RA was added on
the fourth day of EB culture. Mesoderm differentiation was carried
out as previously described [4].
Pharmacological inhibitors. The ERK inhibitor PD184352 [40]
(kind gift of P. Cohen, University of Dundee) was used at a
concentration of 4 lM. The FGF receptor tyrosine kinase inhibitor
SU5402 [39] was used at 5 lM. The c-secretase inhibitor (cat. 565771;
Calbiochem, San Diego, California, United States) was used at a
concentration of 4 lM. None of these inhibitors had any obvious
toxic effects over the time course of the experiments.
Human ES cell culture and differentiation. Undifferentiated
human ES cells (line 181 p99-p130 [71]) were maintained on a layer
of human foreskin ﬁbroblast (line HS27; ATCC, Manassas, Virginia,
United States) in the deﬁned medium N2B27 supplemented with LIF
(10 ng/ml), BMP-4 (3 ng/ml; R & D Systems, Minneapolis, Minnesota,
United States), and bFGF (10 ng/ml; R & D Systems). Cells were
passaged at a split ratio of 1:2 every week using collagenase IV (1 mg/
ml). Feeder-free neural differentiation was performed following the
monolayer protocol used for mouse cells, modiﬁed to suit human ES
cells as follows: cells reaching 50% conﬂuence were incubated in
collagenase IV for 15 min, washed once in PBS and detached in
N2B27 medium supplemented with bFGF (FGF medium, no LIF, no
BMP4) using glass beads. Cells were then incubated for 4 h in a
gelatinised ﬂask in the same medium to allow the differential
attachment of the feeder cells. Finally, the ES suspension was plated
at a 1:1 ratio in culture dishes pre-coated with Matrigel (low growth
factor Matrigel, 1:20; BD Biosciences PharMingen, San Diego,
California, United States). When indicated, the c-secretase inhibitor
(4 lM) was added from the start of the feeder-removal step and then
added every other day when the medium was changed. For coculture
with OP-9 cells, hES cells were treated with collagenase as described
above and then manually detached to avoid carry-over of human
ﬁbroblasts. Cells were then directly plated in FGF medium on a layer
of c-irradiated OP9-EV or OP9-Dl1 stromal cells (kindly provided by
A. Cumano). Matrigel was used to promote the survival of the OP9 in
the serum-free medium. The c-secretase inhibitor was added at
plating and then added every other day when the medium was
changed.
Quantiﬁcation of neural differentiation of human ES cells. Cells
were processed for immunocytochemistry and neural differentiation
quantiﬁed as follows. For OP9 coculture experiments, the number of
colonies with positive PAX-6 cells was counted and normalised to the
total number of colonies in the well. For all experiments (feeder-free
and OP9-dependent differentiation), Volocity image analysis soft-
ware (Improvision, Lexington, Massachusetts, United States) was used
to quantify the extent of differentiation. Brieﬂy, the software was
used to calculate the area of the well (feeder-free experiments) or of
each colony (OP9 experiments) covered by PAX-6–positive nuclei.
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The values were then normalised to the area covered by the cells or
colonies, using DAPI staining. All experiments were repeated at least
three times with four wells per condition.
RT-PCR primers used for RT-PCR are described in Table S1.
Immunoﬂuorescence and FACS. Cells were ﬁxed in 4% parafor-
maldehyde and incubated for 30 min in blocking buffer (PBS, 3%
goat serum, and 0.1% Triton X-100). Primary antibodies were diluted
in blocking buffer and applied for 1 h at room temperature or
overnight at 4 8C. After three washes in PBS, secondary antibodies
conjugated to Alexa ﬂuorophores (Molecular Probes, Eugene,
Oregon, United States) were diluted at 1:1,000 in blocking buffer
and applied for 1 h at room temperature. The cells were washed at
least three times in PBS and visualised on an Olympus inverted
ﬂuorescence microscope. For nuclear counter staining, cells were
incubated in 10 lg/ml DAPI (Sigma, St. Louis, Missouri, United States)
for 10 min after immunostaining.
In experiments where cells were counted, nuclei were counter-
stained with DAPI, at least 1,000 cells per dish were counted from
three separate dishes, and an average was taken. Primary antibodies
were obtained from the following sources: human CD2 (BD
Biosciences), Oct4 (sc-5279; Santa Cruz Biotechnology, Santa Cruz,
California, United States), GFP (Molecular Probes), nestin (Devel-
opmental Studies Hybridoma Bank [DSHB]), Sox2 (Chemicon,
Temecula, California, United States), BLBP (gift of N. Heintz);
neuronal beta-III tubulin (Covance, Madison, Wisconsin, United
States), GFAP (Sigma), TRA 1/60 and TRA 1/81 (Chemicon), human
Sox1 (Chemicon), human Pax6 (Covance), O4 (DSHB), RC2 (DSHB),
Nanog (gift of I. Chambers), cytokeratin 8 (DSHB), Flk1 (AVAS12; gift
of S. Nishikawa [72]), PDGFRa (APA5; gift of S Nishikawa [73]), and E-
cadherin (ECCD2; gift of M. Takeichi [74]).
Single chain antibodies against Jagged1 and Desmin were
generated by the Atlas group at the Sanger Institute (J. McCafferty
and J. Young) as part of the Framework VI Integrated Project
EuroStemCell.
Antibodies obtained from the Developmental Studies Hybridoma
Bank were developed under the auspices of the National Institute of
Child Health and Human Development and maintained by The
University of Iowa, Department of Biological Sciences, Iowa City,
Iowa, United States. TUNEL staining was performed using a DeadEnd
Fluorometric TUNEL detection kit (Promega).
FACS analysis was performed using a Becton-Dickinson (Palo Alto,
California, United States) FACS Calibur ﬂow cytometer. FACS sorting
was carried out on a Dako (Glostrup, Denmark) Cytomation MoFlo
High Performance Cell Sorter.
Supporting Information
Figure S1. Cell Death and Proliferation
(A) Growth curve indicating the total number of cells at various time
points in triplicate monolayer differentiation cultures (average of
triplicates). (B) Proportion of TUNEL-positive cells after 24-h
monolayer differentiation (average of triplicates).
Found at DOI: 10.1371/journal.pbio.0040121.sg001 (203 KB TIF).
Figure S2. c-Secretase Inhibitors Interfere with Neural Speciﬁcation
during Alternative Neural Differentiation Protocols
(A–C) R26NotchIC cells or 46C parental control cells were cultured
for 8 d under the PA6 differentiation protocol in the presence of 4
lM c-secretase inhibitor or the equivalent volume of DMSO. (A, B)
Sox1GFP expression in live colonies (C) quantiﬁcation of the
proportion of colonies containing GFP-positive cells (average of
three independent experiments). (D) R26NotchIC cells or 46C
parental control cells were cultured under the embryoid body plus
RA protocol for 8 d in the presence of 4 lM c-secretase inhibitor or
the equivalent volume of DMSO, and the proportion of Sox1GFPþ
cells was quantiﬁed by FACS analysis after disaggregation of EBs
(average of triplicates).
Found at DOI: 10.1371/journal.pbio.0040121.sg002 (1.7 MB TIF).
Figure S3. Neural Markers in RBPJk-Null Cells after 6 d under the
Monolayer Differentiation Protocol
Monolayer differentiation of RBPJk-null ES cells and the parental D3
ES cell line. Cultures were ﬁxed and stained as indicated on day 6.
Found at DOI: 10.1371/journal.pbio.0040121.sg003 (7.9 MB TIF).
Figure S4. NotchIC Does Not Bypass the Requirement for Retinoic
Acid in Neural Speciﬁcation in the Presence of Serum
R26NotchIC cells or 46C parental control cells were cultured as EBs
(EBs) in the presence or absence of RA. (A) Typical FACS proﬁle for
Sox1GFP in a population of cells from disaggregated EBs. (B and C)
Distribution of Sox1GFP in live EBs.
Found at DOI: 10.1371/journal.pbio.0040121.sg004 (1.8 MB TIF).
Figure S5. NotchIC Suppresses Mesoderm Lineage Choice
FACS analysis of mesoderm markers PDGFRa and Flk1 in NotchIC or
parental controls cells after 5-d culture of collagen IV–coated dishes
in the presence of serum..
Found at DOI: 10.1371/journal.pbio.0040121.sg005 (3.1 MB TIF).
Figure S6. R26NotchIC Cells Generate Neurons and Astrocytes, but
These Are Outnumbered by Undifferentiated BLBPþ Cells unless
Cells Are Exposed to Serum
(A and B) Intact cultures at day 7 of monolayer differentiation,
stained for markers as indicated. (C) Cells replated onto gelatin after
7-d monolayer differentiation, cultured for a further 7 d in the
absence of serum and then for the ﬁnal 7 d in the presence of serum
and 100 units/ml LIF and then ﬁxed and stained for GFAP. (D–K)
Cells replated onto laminin after 7 d of monolayer differentiation
and cultured for a further 14 d and then ﬁxed and stained for
markers as indicated.
Found at DOI: 10.1371/journal.pbio.0040121.sg006 (6.2 MB TIF).
Figure S7. Expression of Notch Ligands in Human ES Cells
RT-PCR for Notch ligands in human ES cells. Human foetal brain
tissue was used as a positive control.
Found at DOI: 10.1371/journal.pbio.0040121.sg007 (628 KB TIF).
Table S1. Primers Used for RT-PCR
Found at DOI: 10.1371/journal.pbio.0040121.st001 (25 KB DOC).
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